Expectations About the COVID-19 Vaccines

NCT ID: NCT04928911

Last Updated: 2024-01-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1176 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-11

Study Completion Date

2023-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study collects information on expectations and attitudes towards the COVID-19 vaccines in participants about to receive a COVID-19 vaccine. This information will be linked to data on side effect occurrence collected in an independent study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

General hypothesis: Negative expectations and attitudes towards the vaccine are associated with a higher risk of side effects

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccine Adverse Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adults receiving COVID-19 vaccine

Adults about to receive a COVID-19 vaccine fill out a questionnaire of potential predictors of side effect occurrence

COVID-19 vaccine

Intervention Type BIOLOGICAL

Adults about to receive a COVID-19 vaccine fill out a questionnaire of potential predictors of side effect occurrence

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

COVID-19 vaccine

Adults about to receive a COVID-19 vaccine fill out a questionnaire of potential predictors of side effect occurrence

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must have signed up to receive a COVID-19 vaccine in Denmark
* Participants are also a part of the ENFORCE study from which outcome data is obtained
* Must be able to read and understand Danish
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lene Vase

Role: STUDY_CHAIR

University of Aarhus

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aarhus University

Aarhus, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AUvac

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.